433 related articles for article (PubMed ID: 34611018)
1. Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study.
Matli K; Chamoun N; Fares A; Zibara V; Al-Osta S; Nasrallah R; Salameh P; Mokhbat J; Ghanem G
Open Heart; 2021 Oct; 8(2):. PubMed ID: 34611018
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort Study.
Chocron R; Galand V; Cellier J; Gendron N; Pommier T; Bory O; Khider L; Trimaille A; Goudot G; Weizman O; Alsac JM; Geneste L; Schmeltz A; Panagides V; Philippe A; Marsou W; Ben Abdallah I; Deney A; El Batti S; Attou S; Juvin P; Delmotte T; Messas E; Pezel T; Planquette B; Duceau B; Gaussem P; Sutter W; Sanchez O; Waldman V; Diehl JL; Mirault T; Bonnet G; Cohen A; Smadja DM;
J Am Heart Assoc; 2021 Apr; 10(8):e018624. PubMed ID: 33550816
[TBL] [Abstract][Full Text] [Related]
3. Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019.
Chow JH; Khanna AK; Kethireddy S; Yamane D; Levine A; Jackson AM; McCurdy MT; Tabatabai A; Kumar G; Park P; Benjenk I; Menaker J; Ahmed N; Glidewell E; Presutto E; Cain S; Haridasa N; Field W; Fowler JG; Trinh D; Johnson KN; Kaur A; Lee A; Sebastian K; Ulrich A; Peña S; Carpenter R; Sudhakar S; Uppal P; Fedeles BT; Sachs A; Dahbour L; Teeter W; Tanaka K; Galvagno SM; Herr DL; Scalea TM; Mazzeffi MA
Anesth Analg; 2021 Apr; 132(4):930-941. PubMed ID: 33093359
[TBL] [Abstract][Full Text] [Related]
4. Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19.
Corrochano M; Acosta-Isaac R; Mojal S; Miqueleiz S; Rodriguez D; Quijada-Manuitt MÁ; Fraga E; Castillo-Ocaña M; Amaro-Hosey K; Albiol N; Soria JM; Antonijoan RM; Souto JC
J Thromb Thrombolysis; 2022 Jan; 53(1):96-102. PubMed ID: 34138399
[TBL] [Abstract][Full Text] [Related]
5. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
; Sadeghipour P; Talasaz AH; Rashidi F; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Jamalkhani S; Khalili H; Yadollahzadeh M; Riahi T; Rezaeifar P; Tahamtan O; Matin S; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Bakhshandeh H; Amin A; Rafiee F; Baghizadeh E; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Dobesh PP; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Bikdeli B
JAMA; 2021 Apr; 325(16):1620-1630. PubMed ID: 33734299
[TBL] [Abstract][Full Text] [Related]
6. High risk of malnutrition among hospitalised coronavirus disease 2019 (COVID-19) patients is associated with mortality and other clinical outcomes.
Guðnadóttir SD; Gunnarsdóttir I; Hernandez UB; Ingadóttir ÁR
Clin Nutr ESPEN; 2024 Jun; 61():1-7. PubMed ID: 38777420
[TBL] [Abstract][Full Text] [Related]
7. The effect of current antithrombotic therapy on mortality in nursing home residents with COVID-19: a multicentre retrospective cohort study.
Boutkourt F; van Haaps T; Brüggemann R; Bhoelan S; Ten Cate H; Kruip MJHA; Spaetgens B; van Es N; Roest T; Joling KJ; Meijer K; Hugtenburg J
Age Ageing; 2024 May; 53(5):. PubMed ID: 38748450
[TBL] [Abstract][Full Text] [Related]
8. Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis.
Meizlish ML; Goshua G; Liu Y; Fine R; Amin K; Chang E; DeFilippo N; Keating C; Liu Y; Mankbadi M; McManus D; Wang SY; Price C; Bona RD; Ochoa Chaar CI; Chun HJ; Pine AB; Rinder HM; Siner JM; Neuberg DS; Owusu KA; Lee AI
Am J Hematol; 2021 Apr; 96(4):471-479. PubMed ID: 33476420
[TBL] [Abstract][Full Text] [Related]
9. Chronic anticoagulation is not associated with a reduced risk of acute kidney injury in hospitalised Covid-19 patients.
Parker K; Hamilton P; Hanumapura P; Castelino L; Murphy M; Challiner R; Thachil J; Ebah L
BMC Nephrol; 2021 Jun; 22(1):224. PubMed ID: 34134645
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial.
Sholzberg M; Tang GH; Rahhal H; AlHamzah M; Kreuziger LB; Áinle FN; Alomran F; Alayed K; Alsheef M; AlSumait F; Pompilio CE; Sperlich C; Tangri S; Tang T; Jaksa P; Suryanarayan D; Almarshoodi M; Castellucci LA; James PD; Lillicrap D; Carrier M; Beckett A; Colovos C; Jayakar J; Arsenault MP; Wu C; Doyon K; Andreou ER; Dounaevskaia V; Tseng EK; Lim G; Fralick M; Middeldorp S; Lee AYY; Zuo F; da Costa BR; Thorpe KE; Negri EM; Cushman M; Jüni P;
BMJ; 2021 Oct; 375():n2400. PubMed ID: 34649864
[TBL] [Abstract][Full Text] [Related]
11. Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review.
Matli K; Farah R; Maalouf M; Chamoun N; Costanian C; Ghanem G
Open Heart; 2021 Jun; 8(1):. PubMed ID: 34099529
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT.
Bohula EA; Berg DD; Lopes MS; Connors JM; Babar I; Barnett CF; Chaudhry SP; Chopra A; Ginete W; Ieong MH; Katz JN; Kim EY; Kuder JF; Mazza E; McLean D; Mosier JM; Moskowitz A; Murphy SA; O'Donoghue ML; Park JG; Prasad R; Ruff CT; Shahrour MN; Sinha SS; Wiviott SD; Van Diepen S; Zainea M; Baird-Zars V; Sabatine MS; Morrow DA;
Circulation; 2022 Nov; 146(18):1344-1356. PubMed ID: 36036760
[TBL] [Abstract][Full Text] [Related]
13. Serum Uric Acid Concentrations and Risk of Adverse Outcomes in Patients With COVID-19.
Chen B; Lu C; Gu HQ; Li Y; Zhang G; Lio J; Luo X; Zhang L; Hu Y; Lan X; Chen Z; Xie Q; Pan H
Front Endocrinol (Lausanne); 2021; 12():633767. PubMed ID: 34025575
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.
Estenssoro E; Loudet CI; Ríos FG; Kanoore Edul VS; Plotnikow G; Andrian M; Romero I; Piezny D; Bezzi M; Mandich V; Groer C; Torres S; Orlandi C; Rubatto Birri PN; Valenti MF; Cunto E; Sáenz MG; Tiribelli N; Aphalo V; Reina R; Dubin A;
Lancet Respir Med; 2021 Sep; 9(9):989-998. PubMed ID: 34224674
[TBL] [Abstract][Full Text] [Related]
15. Association of anticoagulation dose and survival in hospitalized COVID-19 patients: A retrospective propensity score-weighted analysis.
Ionescu F; Jaiyesimi I; Petrescu I; Lawler PR; Castillo E; Munoz-Maldonado Y; Imam Z; Narasimhan M; Abbas AE; Konde A; Nair GB
Eur J Haematol; 2021 Feb; 106(2):165-174. PubMed ID: 33043484
[TBL] [Abstract][Full Text] [Related]
16. Deep vein thrombosis in hospitalized patients with coronavirus disease 2019.
Chang H; Rockman CB; Jacobowitz GR; Speranza G; Johnson WS; Horowitz JM; Garg K; Maldonado TS; Sadek M; Barfield ME
J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):597-604. PubMed ID: 33039545
[TBL] [Abstract][Full Text] [Related]
17. Major bleeding complications in critically ill patients with COVID-19 pneumonia.
Godier A; Clausse D; Meslin S; Bazine M; Lang E; Huche F; Cholley B; Hamada SR
J Thromb Thrombolysis; 2021 Jul; 52(1):18-21. PubMed ID: 33646501
[TBL] [Abstract][Full Text] [Related]
18. Thromboembolic Rates Are Similar Between Intensive Care Unit and Nonintensive Care Unit Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Retrospective Cohort Study.
Worth H; Helmlinger K; Raj R; Heidel E; Lands R
Clin Appl Thromb Hemost; 2021; 27():10760296211053315. PubMed ID: 34786969
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes and the impact of prior oral anticoagulant use in patients with coronavirus disease 2019 admitted to hospitals in the UK - a multicentre observational study.
Arachchillage DJ; Rajakaruna I; Odho Z; Crossette-Thambiah C; Nicolson PLR; Roberts LN; Allan C; Lewis S; Riat R; Mounter P; Lynch C; Langridge A; Oakes R; Aung N; Drebes A; Dutt T; Raheja P; Delaney A; Essex S; Lowe G; Sutton D; Lentaigne C; Sayar Z; Kilner M; Everington T; Shapiro S; Alikhan R; Szydlo R; Makris M; Laffan M
Br J Haematol; 2022 Jan; 196(1):79-94. PubMed ID: 34500500
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort study.
Maximiano Sousa F; Roelens M; Fricker B; Thiabaud A; Iten A; Cusini A; Flury D; Buettcher M; Zukol F; Balmelli C; Zimmermann P; Troillet N; Vuichard-Gysin D; Schreiber PW; Bernhard-Stirnemann S; Tschudin-Sutter S; Nussbaumer-Ochsner Y; Sommerstein R; Gaudenz R; Marschall J; Senn L; Gardiol C; Keiser O; Schüpbach G; Wymann M; Vidondo B; Ch-Sur Study Group
Swiss Med Wkly; 2021 Jul; 151():w20547. PubMed ID: 34324698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
